Search results

Selected filters:

News
Chemicals

Article type

Topic

Sector

Regions

Year

54 results found for your search

Sort options
14 November 2018

UK Supreme Court rejects Warner-Lambert’s pregabalin appeal

Company now faces possibility of £500 million pay-out to the NHS, while ruling could also make second medical use patents harder to obtain and easier to invalidate

13 September 2018

<strong>Chinese biotech patents fail to make mark, more litigation for AbbVie, AIDS Heath Foundation appeals to SCOTUS and much more</strong>

The August edition of our monthly round-up of the life sciences stories you need to know

26 June 2018

Car giants and China’s IP leaders among notable gainers in latest IPO US patent ranking

The Intellectual Property Owners Association (IPO) released its annual ranking yesterday of the 300 companies that received the most US patents in 2017. There was no change at number one as IBM held onto its customary position at the top of the pile…

11 February 2018

GE Ventures licensing head explains the company's new, collaborative approach to IP value creation

Pat Patnode explains how GE's approach to licensing creates opportunities for collaboration and accelerates the rollout of breakthrough technologies.

08 December 2015

It’s not all bad news in the IP market; things may be getting better (in parts, at least)

After the first day of this year’s IP Dealmakers Forum it was hard to pick the appropriate phrase to accurately describe the general sentiment. “Things might just be improving,” was probably the prevailing view, at least in some parts of the market…

31 July 2015

The companies that abandon most US and EPO patents – and shoulder much responsibility for raising quality

In the latest issue of IAM magazine – available for subscribers to view online from today – Matthew Beers and Maria Lazarova of Ocean Tomo take a deep-dive look at patent abandonments data from both the USPTO and EPO. The full article contains a…

16 July 2015

The Innovation Act is pulled, but uncertainty lingers and that’s bad for business

The Innovation Act was dramatically pulled from consideration last night just days before a vote on it was expected in the House of Representatives. It is now unlikely that the proposed legislation will be considered again until after the summer…

30 April 2015

Despite quality and pendency initiatives, the JPO may continue to see a fall in the applications it receives

The Japan Patent Office (JPO) recently published its annual report for 2014. It reveals which companies and universities dominated in terms of JPO-issued patents last year - while also posing some difficult questions for the agency's pendency…

19 January 2015

Hammering “trolls” harms US prosperity, says top BASF IP strategist

US legislators have arrived back on Capitol Hill with patent reform again firmly on the agenda. Congressman Bob Goodlatte, chairman of the House of Representatives Judiciary Committee and author of the Innovation Act in the last Congress, has made…